Cohen, L. A, Marks, P. A, Rifkind, R. A, Amin, S, Desai, D, Pittman, B, and Richon, V. M. (2002). Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. Anticancer Res 22, 1497-1504.

Cohen, T„ and Yao, T. P. (2004). AcK-knowledge reversible acetylation. Sci STKE 2004, pe42.

Creaven, M, Hans, F, Mutskov, V, Col, E, Caron, C, Dimitrov, S„ and Khochbin, S. (1999). Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 38, 8826-8830. Czubryt, M. P, McAnally, J, Fishman, G. I, and Olson, E.'N. (2003). Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100, 1711-1716.

Davis, F. J, Gupta, M, Camoretti-Mercado, B, Schwartz, R. J, and Gupta, M. P. (2003). Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J Biol Chem 278, 20047-20058.

De Nadal, E, Zapater, M, Alepuz, P. M, Sumoy, L, Mas, G, and Posas, F. (2004). The MAPK Hogl recruits Rpd3 histone deacetylase to activate osmoresponsive genes. Nature 427, 370-374.

Deguchi, K, Ayton, P. M, Carapeti, M, Kutok, J. L, Snyder, C. S„ Williams, I. R, Cross, N. C„ Glass, C. K„ Cleary, M. L, and Gilliland, D. G. (2003). MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TlF2-mediated recruitment of CBP. Cancer Cell 3, 259-271. Deleu, L, Shellard, S, Alevizopoulos, K, Amati, B, and Land, H. (2001). Recruitment of TRRAP required for oncogenic transformation by El A. Oncogene 20, 8270-8275. Dequiedt, F, Kasler, H, Fischle, W, Kiermer, V, Weinstein, M, Herndier, B. G„ and Verdin, E. (2003). HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18, 687-698.

Dhalluin, C, Carlson, J. E, Zeng, L, He, C, Aggarwal, A. K, and Zhou, M. M. (1999). Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491-496. Dryden, S. C, Nahhas, F. A, Nowak, J. E, Goustin, A. S, and Tainsky, M. A. (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Mol Cell Biol 23, 3173-3185.

Ehrenhofer-Murray, A. E., Rivier, D. H., and Rine, J. (1997). The role of Sas2, an acetyltransferase homologue of Saccharomyces cerevisiae, in silencing and ORC function. Genetics 145, 923-934.

Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., and Hersch, S. M. (2003). Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23, 9418-9427.

Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, R A., Breslow, R., and Pavletich, N. P. (1999). Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188-193. Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., and Verdin, E. (2002). Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9, 45-57.

Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. M., Livingston, D. M., and Amati, B. (2003). MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4, 575-580.

Fulco, M., Schiltz, R. L., lezzi, S., King, M. T., Zhao, P., Kashiwaya, Y., Hoffman, E., Veech, R. L., and Sartorelli, V. (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12, 51-62. Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., and Horinouchi, S. (2001). Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci USA 98, 87-92.

Gao, L., Cueto, M. A., Asselbergs, F., and Atadja, P. (2002). Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277, 25748-25755.

Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S. F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M, et al. (2000). Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24, 300-303.

Giannakou, M. E., and Partridge, L. (2004). The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14, 408-412.

Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., and Hay, R. T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol Cell 11, 1043-1054. Goodman, R. H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14, 1553-1577. Grant, P. A., Duggan, L., Cote, J., Roberts, S. M., Brownell, J. E., Candau, R., Ohba, R., Owen-Hughes, T., Allis, C. D., Winston, F, et al. (1997). Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev 77,1640-1650.

Grant, P. A., Schieltz, D„ Pray-Grant, M. G„ Yates, J. R., 3rd, and Workman, J. L. (1998). The ATM-related cofactor Tral is a component of the purified SAGA complex. Mol Cell 2, 863-867. Gregoire, S., and Yang, X. J. (2005). Association with class Ila histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol Cell Biol 25, 2273-2287. Grozinger, C. M., Hassig, C. A., and Schreiber, S. L. (1999). Three proteins define a class of human histone deacetylases related to yeast Hdalp. Proc Natl Acad Sci USA 96, 4868-4873. Grozinger, C. M., and Schreiber, S. L. (2000). Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 97, 7835-7840.

Gu, W„ and Roeder, R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.

Guardiola, A. R., and Yao, T. P. (2002). Molecular cloning and characterization of a novel histone deacetylase HDAC 10. J Biol Chem 277, 3350-3356.

Guarente, L., and Picard, F. (2005). Calorie restriction-the SIR2 connection. Cell 120, 473-482.

Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., and Schreiber, S. L. (2003). Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100, 4389-4394. Harlow, E., Whyte, P., Franza, B. R., Jr., and Schley, C. (1986). Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol 6, 1579-1589. Heinzel, T., Lavinsky, R. M., Mullen, T. M., Soderstrom, M., Laherty, C. D„ Torchia, J., Yang, W. M„ Brard, G., Ngo, S. D„ Davie, J. R., et al. (1997). A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.

Herold, C., Ganslmayer, M., Ocker, M., Hermann, M., Geerts, A., Hahn, E. G., and Schuppan, D. (2002). The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 36, 233-240. Hilfiker, A., Hilfiker-Kleiner, D., Pannuti, A., and Lucchesi, J. C. (1997). mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. Embo J 16, 2054-2060.

Hockly, E., Richon, V. M., Woodman, B., Smith, D. L„ Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A., et al. (2003). Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 100, 2041-2046.

Horlein, A. J., Naar, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C. K., and et al. (1995). Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404.

Horn, P. J., and Peterson, C. L. (2002). Molecular biology. Chromatin higher order folding-wrapping up transcription. Science 297, 1824-1827.

Howe, L., Auston, D., Grant, P., John, S., Cook, R. G., Workman, J. L., and Pillus, L. (2001). Histone H3 specific acetyltransferases are essential for cell cycle progression. Genes Dev 15, 3144-3154.

Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196. Hu, S. C., Chrivia, J., and Ghosh, A. (1999). Regulation of CBP-mediated transcription by neuronal calcium signaling. Neuron 22, 799-808.

Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X. F„ and Yao, T. P. (2002). HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458.

Hughes, R. E. (2002). Polyglutamine disease: acetyltransferases awry. Curr Biol 12, R141-143.

Humphrey, G. W., Wang, Y., Russanova, V. R., Hirai, T., Qin, J., Nakatani, Y., and Howard, B. H. (2001). Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-Ll. J Biol Chem 276, 6817-6824.

Ikura, T., Ogryzko, V. V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J., and Nakatani, Y. (2000). Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102, 463-473.

Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800. Imhof, A., Yang, X. J., Ogryzko, V. V., Nakatani, Y„ Wolffe, A. P., and Ge, H. (1997). Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 7, 689-692. Itazaki, H., Nagashima, K, Sugita, K., Yoshida, H., Kawamura, Y., Yasuda, Y., Matsumoto, K., Ishii, K, Uotani, N., Nakai, H., and et al. (1990). Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. J Antibiot (Tokyo) 43, 1524-1532. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E„ and Yao, T. P. (2002). MDM2-HDAC 1 -mediated deacetylation of p53 is required for its degradation. Embo J 21, 6236-6245.

Ivanov, D., Schleiffer, A., Eisenhaber, F., Mechtler, K., Haering, C. H., and Nasmyth, K. (2002). Ecol is a novel acetyltransferase that can acetylate proteins involved in cohesion. Curr Biol 12,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment